Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now full pipeline small index

Systemic Inflammatory Response Syndrome: full-pipeline trial registry

3 of 6 indexed Systemic Inflammatory Response Syndrome trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Systemic Inflammatory Response Syndrome: 6 US clinical trials tracked, 3 recruiting.

Systemic Inflammatory Response Syndrome is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is CalciMedica, running 1 of these trials.

Enrollment posture brief

Registry condition systemic-inflammatory-response-syndrome

OPEN 3 | RECR 50% | LATE 1 | EARLY 1 | RANK #2866 | SPON 1

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Systemic Inflammatory Re (th…50%
Open-enrollment share among volume-matched conditions near Systemic Inflammatory Response Syndrome

Systemic Inflammatory Response Syndrome lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Systemic Inflammatory Response Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Systemic Inflammatory Response Syndrome is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Systemic Inflammatory Response Syndrome research.

    CalciMedica accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Systemic Inflammatory Response Syndrome enrolment sits around 137 participants.

    Median target enrolment is 137 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Systemic Inflammatory Response Syndrome splits between interventional and observational designs.

    3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Systemic Inflammatory Response Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Jevity 1.5 Other
1 trials
CM-4620 Injectable Emulsion or CM-4620-IE Drug
1 trials
Gene Z or other rapid diagnostic techniques developed in our lab (as of 2018 not using Gene Z - now using In-Dx along with other developed techniquesregularly) Device
1 trials
Angiotensin II and hydrocortisone sodium succinate Drug
1 trials
miRNA in Sepsis Procedure
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Systemic Inflammatory Response Syndrome trials. A trial with sites in several states counts in each.

New York 2 trials
Michigan 2 trials
Illinois 2 trials
Arizona 2 trials
Missouri 1 trials
Minnesota 1 trials
Maryland 1 trials
Kentucky 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Systemic Inflammatory Response Syndrome page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Systemic Inflammatory Response Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • CalciMedica sponsors the most Systemic Inflammatory Response Syndrome trials on record, review their full trial history before evaluating a specific study. See CalciMedica's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Systemic Inflammatory Response Syndrome condition card totals 6 registered trials; most-linked intervention Jevity 1.5; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.